Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $241.93M.
ENTERPRISE VALUE (EV)
$241.93M
Cabaletta Bio, Inc.
Market Cap
$322.03M
Enterprise Value (EV)
$241.93M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $322.03M | $241.93M |
| ClearPoint Neuro, Inc. (CLPT)vs › | $322.39M | $356.97M |
| Sanara MedTech Inc. (SMTI)vs › | $321.67M | $354.77M |
| Avita Medical Inc. (RCEL)vs › | $319.67M | $359.02M |
| CapsoVision, Inc. (CV)vs › | $325.56M | $317.17M |
| Agenus Inc. (AGEN)vs › | $316.90M | $338.87M |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.46M | $291.71M |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $304.00M | $135.33M |
| Benitec Biopharma Inc. (BNTC)vs › | $303.86M | $124.65M |
| Relmada Therapeutics, Inc. (RLMD)vs › | $349.81M | $338.47M |
Market Cap
$322.03M
Total Debt
$2.88M
Cash
$82.98M
Enterprise Value
$241.93M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
